What have we learned from 10-k 1. P2b results are
Post# of 72440
(Total Views: 329)
Posted On: 09/11/2018 7:13:47 PM
What have we learned from 10-k
1. P2b results are available. We don’t know how much we owe CRO. We also don’t know what the results say. Good or bad.
2. Some BP is interested in B-OM. Doing DD.
Everything else seems boiler plate to me.
Am I missing anything?
My conclusion: Aspire has no choice but to buy more stock to protect their investment unless a partnership is finalized.
Anyone else have thoughts?
1. P2b results are available. We don’t know how much we owe CRO. We also don’t know what the results say. Good or bad.
2. Some BP is interested in B-OM. Doing DD.
Everything else seems boiler plate to me.
Am I missing anything?
My conclusion: Aspire has no choice but to buy more stock to protect their investment unless a partnership is finalized.
Anyone else have thoughts?
(2)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼